Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNA - PubMed (original) (raw)
. 1998 Mar 27;279(5359):2103-6.
doi: 10.1126/science.279.5359.2103.
X Jin, S Bonhoeffer, P R Dunbar, M A Nowak, S Monard, J P Segal, Y Cao, S L Rowland-Jones, V Cerundolo, A Hurley, M Markowitz, D D Ho, D F Nixon, A J McMichael
Affiliations
- PMID: 9516110
- DOI: 10.1126/science.279.5359.2103
Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNA
G S Ogg et al. Science. 1998.
Abstract
Although cytotoxic T lymphocytes (CTLs) are thought to be involved in the control of human immunodeficiency virus-type 1 (HIV-1) infection, it has not been possible to demonstrate a direct relation between CTL activity and plasma RNA viral load. Human leukocyte antigen-peptide tetrameric complexes offer a specific means to directly quantitate circulating CTLs ex vivo. With the use of the tetrameric complexes, a significant inverse correlation was observed between HIV-specific CTL frequency and plasma RNA viral load. In contrast, no significant association was detected between the clearance rate of productively infected cells and frequency of HIV-specific CTLs. These data are consistent with a significant role for HIV-specific CTLs in the control of HIV infection and suggest a considerable cytopathic effect of the virus in vivo.
Similar articles
- Human immunodeficiency virus type 1-specific cytotoxic T lymphocyte activity is inversely correlated with HIV type 1 viral load in HIV type 1-infected long-term survivors.
Betts MR, Krowka JF, Kepler TB, Davidian M, Christopherson C, Kwok S, Louie L, Eron J, Sheppard H, Frelinger JA. Betts MR, et al. AIDS Res Hum Retroviruses. 1999 Sep 1;15(13):1219-28. doi: 10.1089/088922299310313. AIDS Res Hum Retroviruses. 1999. PMID: 10480635 - Inverse correlation between memory Gag-specific cytotoxic T lymphocytes and viral replication in human immunodeficiency virus-infected children.
Buseyne F, Le Chenadec J, Corre B, Porrot F, Burgard M, Rouzioux C, Blanche S, Mayaux MJ, Rivière Y. Buseyne F, et al. J Infect Dis. 2002 Dec 1;186(11):1589-96. doi: 10.1086/345482. Epub 2002 Nov 1. J Infect Dis. 2002. PMID: 12447734 - Cytotoxic-T-cell responses, viral load, and disease progression in early human immunodeficiency virus type 1 infection.
Musey L, Hughes J, Schacker T, Shea T, Corey L, McElrath MJ. Musey L, et al. N Engl J Med. 1997 Oct 30;337(18):1267-74. doi: 10.1056/NEJM199710303371803. N Engl J Med. 1997. PMID: 9345075 - Correlates of cytotoxic T-lymphocyte-mediated virus control: implications for immunosuppressive infections and their treatment.
Wodarz D, Nowak MA. Wodarz D, et al. Philos Trans R Soc Lond B Biol Sci. 2000 Aug 29;355(1400):1059-70. doi: 10.1098/rstb.2000.0643. Philos Trans R Soc Lond B Biol Sci. 2000. PMID: 11186307 Free PMC article. Review. - AIDS: decline and fall of immune surveillance?
Feinberg MB, McLean AR. Feinberg MB, et al. Curr Biol. 1997 Mar 1;7(3):R136-40. doi: 10.1016/s0960-9822(97)70072-1. Curr Biol. 1997. PMID: 9162473 Review.
Cited by
- Current situation in the development of a preventive HIV vaccine.
Alcamí J, Joseph Munné J, Muñoz-Fernández MÁ, Esteban M. Alcamí J, et al. Enferm Infecc Microbiol Clin. 2005 Jul;23:15-24. doi: 10.1016/S0213-005X(05)75157-0. Epub 2009 Jan 6. Enferm Infecc Microbiol Clin. 2005. PMID: 38620211 Free PMC article. - HIV-1 protective epitope-specific CD8+ T cells in HIV-1-exposed seronegative individuals.
Chikata T, Gatanaga H, Nguyen HT, Mizushima D, Zhang Y, Kuse N, Oka S, Takiguchi M. Chikata T, et al. iScience. 2023 Sep 29;26(11):108089. doi: 10.1016/j.isci.2023.108089. eCollection 2023 Nov 17. iScience. 2023. PMID: 37867946 Free PMC article. - Definition of a New HLA B*52-Restricted Rev CTL Epitope Targeted by an HIV-1-Infected Controller.
El Kenz B, Schmidt KG, Ogungbemi-Alt VK, Bergmann S, Steininger P, Korn K, Spriewald B, Harrer EG, Nganou-Makamdop K, Harrer T. El Kenz B, et al. Viruses. 2023 Feb 18;15(2):567. doi: 10.3390/v15020567. Viruses. 2023. PMID: 36851781 Free PMC article. - T cell receptor-targeted immunotherapeutics drive selective in vivo HIV- and CMV-specific T cell expansion in humanized mice.
Li M, Garforth SJ, O'Connor KE, Su H, Lee DM, Celikgil A, Chaparro RJ, Seidel RD, Jones RB, Arav-Boger R, Almo SC, Goldstein H. Li M, et al. J Clin Invest. 2021 Dec 1;131(23):e141051. doi: 10.1172/JCI141051. J Clin Invest. 2021. PMID: 34673568 Free PMC article. - Elevated glycolysis imparts functional ability to CD8+ T cells in HIV infection.
Rahman AN, Liu J, Mujib S, Kidane S, Ali A, Szep S, Han C, Bonner P, Parsons M, Benko E, Kovacs C, Yue FY, Ostrowski M. Rahman AN, et al. Life Sci Alliance. 2021 Sep 21;4(11):e202101081. doi: 10.26508/lsa.202101081. Print 2021 Nov. Life Sci Alliance. 2021. PMID: 34548381 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical